• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Detection of viable organisms in leprosy patients treated with multidrug therapy.

作者信息

Gupta U D, Katoch K, Singh H B, Natrajan M, Sharma V D, Katoch V M

机构信息

Central Jalma Institute for Leprosy (ICMR), Taj Ganj, Agra, India.

出版信息

Acta Leprol. 1999;11(3):89-92.

PMID:10544720
Abstract

Cutaneous biopsies were collected from multibacillary leprosy patients who attended the out-patient department of Jalma Institute for treatment at different time intervals, i.e. 6 months, 12 months, 18 months, 24 months, 30 months, 36 months and 42 months after starting multidrug therapy (MDT) when they were still skin smear positive. Biopsies were processed for inoculation into mouse foot pad (MFP) and estimation of bacillary ATP levels by bioluminescent assay (ATP assay) by earlier established procedures. Viable bacilli were detectable after 1 year (25% cases by MFP and 31% cases by ATP assay), 2 years (8% cases by MFP and 12% cases by ATP assay) and 3 years (4% cases by both MFP and ATP assays). Overall, the percentage of the persisters was 10% by MFP and 13% by ATP assay. It would be important to carry out surveillance studies in larger number of BL/LL cases to know the trends and also the resultant relapses.

摘要

相似文献

1
Detection of viable organisms in leprosy patients treated with multidrug therapy.
Acta Leprol. 1999;11(3):89-92.
2
Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.用改良酚法、ATP生物发光法和基因扩增法分析麻风病活力测定之间的定量关系。
Int J Lepr Other Mycobact Dis. 2001 Dec;69(4):328-34.
3
Persister studies in leprosy patients after multi-drug treatment.多药治疗后麻风病患者的持留菌研究
Int J Lepr Other Mycobact Dis. 2005 Jun;73(2):100-4.
4
Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?在接受12个月和24个月的多药治疗后,瘤型麻风患者体内是否仍存在活的麻风分枝杆菌?
Indian J Lepr. 2004 Jul-Sep;76(3):199-206.
5
Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.在采用多药联合化疗方案(使用常规药物以及米诺环素和氧氟沙星等新药)治疗的多菌型病例中,通过正常小鼠足垫和杆菌ATP生物发光测定法评估存活率。
Indian J Lepr. 2000 Oct-Dec;72(4):437-42.
6
Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.麻风杆菌的活力测定:正常小鼠足垫与细菌ATP生物发光测定法的比较
Acta Leprol. 1997;10(4):209-12.
7
Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.多药联合化疗固定疗程24个月后涂片阳性麻风患者的鼻黏膜和皮肤:组织病理学及微生物学研究
Int J Lepr Other Mycobact Dis. 1999 Sep;67(3):292-7.
8
10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.对接受联合化疗和免疫治疗的高菌量瘤型/界线类偏瘤型麻风患者进行10至12年的随访。
Vaccine. 2004 Sep 9;22(27-28):3649-57. doi: 10.1016/j.vaccine.2004.03.037.
9
Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.12个月的世界卫生组织/多药联合治疗麻风病方案与结核分枝杆菌疫苗联合用于多菌型麻风病:136例患者的随访
Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):174-81.
10
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.采用传统药物及新型药物氧氟沙星和米诺环素治疗多菌型麻风患者时,治疗对PCR阳性率的影响。
Acta Leprol. 1999;11(4):179-82.